跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML
Approved
THERAPEUTIC
FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML
Baxter Pharmaceuticals India Private Limited (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Nov 23, 2017
Approval ID
06f6a4bea57a417b
Company
Baxter Pharmaceuticals India Private Limited (INDIA)
Type
Therapeutic
Approval Details
Approval Id
06f6a4bea57a417b
Drug Name
FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML
Product Name
FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML
Approval Number
SIN15365P
Approval Date
2017-11-23
Registrant
BAXTER HEALTHCARE (ASIA) PTE LTD
Licence Holder
BAXTER HEALTHCARE (ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR
Atc Code
C03CA01
Atc Item Name
furosemide
Pharma Manufacturer Name
BAXTER HEALTHCARE (ASIA) PTE LTD
Active Ingredients
Furosemide
50 mg/5 mL
FUROSEMIDE
50 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 23, 2017
Approval ID
06f6a4bea57a417b
Type
Therapeutic
Back to HSA Approvals
